Liraglutide for the Treatment of Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Placebo-Controlled Trials

被引：0
|
作者：
Qiang Du
Yan-Jun Wang
Sheng Yang
Yue-Yang Zhao
Ping Han
机构：
[1] Shengjing Hospital of China Medical University,Department of Endocrinology
[2] Shengjing Hospital of China Medical University,Library
来源：
Advances in Therapy | 2014年 / 31卷
关键词：
Glucagon-like peptide 1; Liraglutide; Meta-analysis; Randomized controlled trial; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1182 / 1195
页数：13
相关论文
共 50 条
  • [41] EFFICACY AND SAFETY OF DULAGLUTIDE IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Kanukula, R.
    Likhar, N.
    Mothe, R. K.
    Dang, A.
    VALUE IN HEALTH, 2016, 19 (03) : A198 - A199
  • [42] Baduanjin Exercise for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Wen, Junmao
    Lin, Tong
    Cai, Yinhe
    Chen, Qianying
    Chen, Yuexuan
    Ren, Yueyi
    Weng, Senhui
    Wang, Boqing
    Ji, Shuliang
    Wu, Wei
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2017, 2017
  • [43] Glycemic Control and Cardiovascular Events in Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
    Khraisat, Ahmad
    Bahekar, Amol
    Artin, Bassel
    Bhuriya, Rohit
    Al-Jaghbeer, Eshraq
    Singh, Sarabjeet
    Molnar, Janos
    Khosla, Sandeep
    Arora, Rohit
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A219 - A219
  • [44] Effects of Probiotic Supplementation on Dyslipidemia in Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
    Wang, Chen
    Zhang, Chengcheng
    Li, Sijia
    Yu, Leilei
    Tian, Fengwei
    Zhao, Jianxin
    Zhang, Hao
    Chen, Wei
    Zhai, Qixiao
    FOODS, 2020, 9 (11)
  • [45] Placebo-controlled trials in type 2 diabetes
    Misbin, RI
    DIABETES CARE, 2001, 24 (04) : 773 - 774
  • [46] Efficacy and safety of liraglutide in type 2 diabetes mellitus patients complicated with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials
    Wang, Lidan
    Xin, Qiqi
    Wang, Ya
    Chen, Zhuhong
    Yuan, Rong
    Miao, Yu
    Zhang, Guangde
    Cong, Weihong
    PHARMACOLOGICAL RESEARCH, 2021, 171
  • [47] Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials
    Rehman, M. B.
    Tudrej, B. V.
    Soustre, J.
    Buisson, M.
    Archambault, P.
    Pouchain, D.
    Vaillant-Roussel, H.
    Gueyffier, F.
    Faillie, J. -L.
    Perault-Pochat, M. -C.
    Cornu, C.
    Boussageon, R.
    DIABETES & METABOLISM, 2017, 43 (01) : 48 - 58
  • [48] Dapagliflozin treatment for type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
    Zhang, Mei
    Zhang, Lin
    Wu, Bin
    Song, Haolan
    An, Zhenmei
    Li, Shuangqing
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2014, 30 (03) : 204 - 221
  • [49] Metabolic surgery for the treatment of type 2 diabetes: A network meta-analysis of randomized controlled trials
    Cresci, Barbara
    Cosentino, Claudia
    Monami, Matteo
    Mannucci, Edoardo
    DIABETES OBESITY & METABOLISM, 2020, 22 (08): : 1378 - 1387
  • [50] Ethics of placebo-controlled trials in patients with type 2 diabetes mellitus - Response
    Fonseca, V
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02): : 823 - 824
12345